BioSpace News Archive

Heron Therapeutics, Inc. today hosted a fireside chat with the U.S. Surgeon General, Vice Admiral Jerome M. Adams, M.D., M.P.H.

Award-Winning Team Partners with Dispensary Owners, Industry Newcomers and Multi-Unit Franchisees

- Data support ongoing evaluation of Synthetic BioticTM SYNB1020 for the potential treatment of hyperammonemia -

Titan Medical Inc. announces financial results for the three and nine months ended September 30, 2018.

Angion Biomedica and Sinovant Sciences today announced a collaboration and license agreement for BB3, Angion’s investigational small molecule mimetic of hepatocyte growth factor (HGF), in the People’s Republic of China, Hong Kong, Macau, and Taiwan (Greater China).

Walgreens Boots Alliance, Inc. announced today that Executive Vice President and Global Chief Financial Officer James Kehoe will participate in a fireside chat at the Credit Suisse 27th Annual Healthcare Conference at The Phoenician, Scottsdale, Ariz. on Wednesday, November 14 at 10:55 a.m. Mountain time (12:55 p.m. Eastern time).

TherapeuticsMD, Inc. today announced that the company will participate in three upcoming healthcare investor conferences. Chief Executive Officer Robert G. Finizio will provide an overview of the company at the conferences.

33 vendors and research organizations now collaborating on developing standard parallel programming model

The Antibody-Drug Conjugate community will join together for the 9th World ADC San Diego on November 12-15 at the Marriott Marquis San Diego with key influential researchers from around the world, to discuss clinical research experiences to help further the development of cancer therapeutics.

Prometic Life Sciences Inc. announced today that it will report its financial results for the third quarter ended September 30, 2018 on Wednesday November 14, 2018 after market close.